When you look at what they have in pre clinical and clinical trials and if results of this research prove fruitfull yes this may well be a $100 plus stock but not forgetting launch of insomnia and ezcema preperations in near future will at least hit 20 to 30 cent mark imo
Ann: June 2017 Quarterly Report, page-25
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.020(4.00%) |
Mkt cap ! $5.447M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 48.0¢ | $5.343K | 10.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10157 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 576 | 2 |
View Market Depth
| Last trade - 15.31pm 24/05/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |